Organic compounds -- part of the class 532-570 series – Organic compounds – Pteroyl per se or having -c- – wherein x is chalcogen – bonded...
Patent
1993-07-29
1994-07-12
Chang, Celia
Organic compounds -- part of the class 532-570 series
Organic compounds
Pteroyl per se or having -c-, wherein x is chalcogen, bonded...
544277, 536 276, C07D48706, C07D47330, C07H 1906
Patent
active
053290070
ABSTRACT:
Adenosine analogues which act selectively at adenosine receptors and which act in general as adenosine antagonists are disclosed. From in vitro studies it is known that specific physiological effects can be distinguished as a result of this selectivity and that adenosine receptor activity in vitro correlates with adenosine receptor activity in vivo.
Pharmaceutical preparations of the subject compounds can be prepared on the basis of the selective binding activity of the compounds disclosed herein which will enhance certain physiological effects while minimizing others, such as decreasing blood pressure without decreasing heart rate.
REFERENCES:
patent: 3092632 (1963-06-01), Zwahlen
patent: 3114751 (1963-12-01), Whetstone
patent: 3225029 (1965-12-01), Yaniaoka
patent: 3399196 (1968-08-01), Druey et al.
patent: 3590029 (1971-06-01), Koch et al.
patent: 3813394 (1974-05-01), Tensho et al.
patent: 3862189 (1975-01-01), Schwender
patent: 3936454 (1976-02-01), Schwender
patent: 4514405 (1985-04-01), Irmsher
patent: 4853386 (1989-07-01), Friebe et al.
patent: 4904666 (1990-02-01), Friebe et al.
Brajeswar et al "Inhibitors of Nucleoside Transports" CA 83:172423v RN 56964-93-3 (1975).
Brajeswar et al "Inhibitors of Nucleoside Transport" J. Med. Chem. 18(10) 968-973 (1975).
Cheng et al "Potential purine antagonists" J. Org Chem. 23 191-200 (1958).
J. L. Avila, et al., Biological Action of Pyrazolopyrimidine Derivatives Against Tyrpanosoma Cruzi, Comp. Biochem. Physiol., 86C(1), 49-54 (1987).
J. L. Avila, et al., Action of Pyrazolopyrimidine Derivatives on Tyrpanosoma Rangeli Culture Forms, Comp. Biochem. Physiol., 83C(2), 291-294 (1986).
J. L. Avila, et al., Action of Pyrazolopyrimidine Derivatives on American Leishmania SPP. Promastigotes, Comp. Biochem. Physiol., 83C(2), 285-289 (1986).
C. C. Cheng, et al., Potential Purine Antagonists. VI., Contribution from the Dept. of Chem., New Mexico Highlands University, 1240-1256 (1956).
E. Y. Sutcliffe, et al., Potential Purine Antagonists. XXXII., J. Med. Pharm. Chem., 5, 588-607 (1962).
H. E. Skipper, et al., Structure-Activity Relationships Observed on Screening a Series of Pyrazolopyrimidines Against Experimental Neoplasms, Cancer Res., 17, 579-596 (1957).
B. L. Lynch, et al., Potential Purine Antagonists. Part X., Dept. of Chem., New Mexico Highlands University, 2973-2981 (1958).
J. W. Daly, et al., Structure-Activity Relationships for N.sup.6 -Substituted Adenosines at a Brain A.sub.1 -Adenosine Receptor with a Comparison to an A.sub.2 -Adenosine Receptor Regulating Coronary Blood Flow, Biochem. Pharm., 35(15), 2467-2481 (1986).
G. A. Bhat, et al., Pyrazolopyrimidine Nucleosides. 12., J. Med. Chem., 24, 1165-1172 (1981).
Lentz Nelsen L.
Peet Norton P.
Chang Celia
Merrell Dow Pharmaceuticals Inc.
Sayles Michael J.
LandOfFree
Selective adenosine receptor agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selective adenosine receptor agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective adenosine receptor agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-397471